hotspot -WSS

hotspot

author：leisure time 2025-10-02 05:38:16 - browse：67

Sanofi will license a new CRISPR enzyme from the startup Scribe Therapeutics in a bid to be the first to develop a safer, simpler, and more scalable cure for sickle cell disease.

The French drugmaker will pay Scribe $40 million upfront and promise another $1.2 billion in potential milestones to license a DNA-cutting enzyme called CasX for use in a potential single-infusion treatment for the serious blood disorder — what’s known as in vivo therapy.CasX was discovered in CRISPR pioneer Jennifer Doudna’s lab, which subsequently spun out Scribe.

Scribe was planning to announce the news Tuesday, but it was published early Monday by GEN.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Activists slam private health insurers over coverage restrictions
Next article： Vertigo drug brings hope for rare neuron disorder, Niemann

WSS

New Ultima Genomics DNA sequencer can read genome for $100

Covid’s new normal has set in amid another rise in cases

Medicare drug price negotiation’s day in court

Some dementia cases could be undiagnosed liver disease

Cognito secures funding to test medical device for Alzheimer's

Grad students accuse University of California of wage theft

hotspot

hotspot

leisure time

Novavax promises a turnaround & Lilly roils the obesity market

ARCH Venture Partners is raising $3 billion for a life sciences fund

Apple is now the first public company to be valued at $3 trillion

Juul spent big to court Black leaders to promote its e

Walensky prepares to leave CDC — and Congress — behind

Patients, doctors press FTC to beef up hospital merger scrutiny

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Vertex non

United colonoscopy coverage change 'may cost lives,' doctors say

Time to name cancers by genetics, not organ of origin, expert says

explore

Assistant physicians can help address the primary care shortage

Senate bill would ban some hospital facility fees

Akili changes sales model for its ADHD video game treatment

Medicare drug price negotiation’s day in court

Grad students accuse University of California of wage theft

SAMSHA loosens regulations on methadone treatment centers

entertainment

explore

leisure time

focus